All news

(Image: Getty/Mohd Hafiez Mohd Razali / EyeEm)

WHO indicates preferred HIV treatment

By Vassia Barba

Citing evidence from two completed clinical trials, the WHO recommends dolutegravir as the preferred treatment for all patients with HIV.

(Image: Getty/Monsitj)

Sales of Keytruda leads Merck to strong Q2

By Ben Hargreaves

Sales of immunotherapy treatment, Keytruda, were up by 58% year-on-year, which led Merck to a sales increase of 12% overall compared to 2018.

(Image: Getty/BrianAJackson)

July roundup sees flurry of partnership deals

By Ben Hargreaves

The summer months are traditionally slow on movements across the industry, but July saw a number of manufacturing partnership deals take place as companies look ahead to product commercialization.

Follow us

Products

View more

Webinars